Julie Peffer
Analyst · William Blair
Thank you, Mandy. Let's turn to our third quarter results. Revenue for the third quarter was $40.7 million compared to $40.2 million in the third quarter of 2021, about 1% year-over-year growth and 8% quarter-over-quarter growth driven primarily by the September award of the GFIM OE Phase 2 contract. Our Analytics segment drove $22.7 million of revenue this quarter compared to about $21 million over the same period last year, which is 8% year-over-year growth, largely attributable to the addition of ProModel and the GFIM award in September. As we stated last quarter, we expect our Analytics segment that drives higher margins to continue to grow faster than C&E, which will improve our overall margins as our business mix shift. Revenue in C&E was $18 million this quarter compared to $19.2 million in Q3 of last year. The decrease was primarily the result of lower volumes on certain procurement programs. Backlog was $288 million at the end of Q3, which is down 11% compared to last quarter. This was largely driven by contracts converting in Q3 revenue as well as a few contracts with expired period of performance at the end of the federal government fiscal year. For these time and material contracts, the customer did not spend to their contractual limits, so our backlog was reduced for any remaining funds when the period of performance was completed. This is a result of the ongoing shifting priorities we've seen throughout the year. We are continuing to review our backlog in detail to ensure we have integrated a common methodology and practical application across all of our acquired businesses as we move forward. As a reminder, we revised our backlog calculation methodology in the second quarter to more accurately depict awarded contracts from 5 categories into 4: funded, unfunded, priced unexercised options, and unpriced unexercised options. Even with this quarter's reduction, our firm backlog comprised of funded, unfunded and priced unexercised options is still up 54% since December 2020. In the third quarter, our unadjusted gross margin was 29%, up from 27% for Q3 2021 driven primarily by increased margins on analytics contracts. Our adjusted gross margin was 34% compared to 36% year-over-year due to the impact of less development work in Q3 2022 compared to last year. This also reduced year-over-year adjusted gross margin in analytics from 49% in Q3 2021 to 43% in Q3 2022. Segment adjusted gross margin for C&E was 22% compared to 21% in Q3 2021. Now turning to operating expenses. For Q3, operating expenses were $24 million, including R&D expenses of $1.8 million and SG&A expenses of $20.2 million. We also booked $1.6 million of restructuring costs and $600,000 of transaction costs in our Q3 operating expenses that are categorized as nonrecurring, although Q3 operating expenses were higher than the same period last year due to public company and infrastructure costs as well as integrated related expenses. When you exclude the $2.2 million of nonrecurring expenses, Q3 is a sequential decrease of approximately $7.5 million or a 25% reduction versus Q2. This reduction was largely driven by the actions we are taking to rightsize our cost structure to better align expenses and cash flow with our revised revenue expectations for the year. As part of the rightsizing actions initiated in Q3, we elected to slow some of our internal investments, which require the difficult decision to execute a reduction in force at the end of August. This was a contributing factor in our sequential operating expense decline. In addition, we reassigned a significant number of G&A and R&D employees from internal projects to open billable roles, which reduced our G&A expense while fulfilling existing and new contractual obligations without additional hiring. We also reduced vendor expenses, including facilities expenses associated with reduced office space in several locations where we expect to realize additional savings in Q4. In total, we've identified more than $20 million of annualized savings in both labor and vendor reductions. This work continues and we expect to be operating at this new annualized run rate during Q4, which will enable us to meet our previous guidance commitment of negative single-digit loss in the second half of 2022. Going forward, as Mandy described, we will continue to identify repeatable patterns that allow us to run our business as efficiently as possible, and we will continue to take a more disciplined approach to managing operational expenses and growth investments. With rigorous cost management and good housekeeping, we will efficiently deploy capital for targeted investments that yield sustainable growth. Overall, we posted a net loss of $16.1 million for the third quarter of 2022, which included $2.2 million of stock-based compensation expense, $1.6 million of restructuring-related expense, $1.2 million of D&O insurance and $600,000 related to transaction fees. Our adjusted EBITDA loss was $3.9 million, which is nearly a 50% improvement from Q2 with only 1 month of realized cost savings. Additionally, we made a year-to-date adjustment in our management bonus accrual to align with full year projected performance. Now turning to the balance sheet. We ended the quarter with cash and cash equivalents of approximately $22 million. This represents an $8 million burn since Q2, but also includes $2.2 million of nonrecurring expenses for severance and transaction fees. The structural cost reductions we have made will allow us to minimize our cash burn going forward. Just this week, we are finalizing our credit facility amendment with Bank of America to better align with our current business needs. The revised facility will give us access of up to $25 million of liquidity upon fulfillment of the agreement covenants. As I've just described, we anticipate substantially lower cash burn going forward, and we believe our solid liquidity position enables us to target our growth investments judiciously. Now turning to our financial outlook. Today, we are reaffirming our guidance of expected 2022 revenue in the range of $150 million to $170 million. We anticipate strong year-over-year growth in commercial revenue, comprising approximately 8% to 10% of second half revenue. Following our successful cost reduction initiatives, we continue to expect adjusted EBITDA to be in the negative single-digit million for second half of 2022. Looking ahead, we continue to expect gross margins to expand as revenue shifts towards software and our backlog remains strong. Our product strategy and go-to-market efforts remain core to our growth, and we will focus on driving efficiencies as we continue to find rare earth opportunities and ramp up in a sustainable way. I'd like to turn over the call to Mandy for closing remarks.